Sign in
4

Changes in Ownership

Voyager Therapeutics, Inc. Filed Acc 0001104659-20-044247

Senior VP & General Counsel sold 3,091 shares at $8.51 ($26,304)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hesslein Robert W. Senior VP & General Counsel 2020-04-03 Sale −3,091 $8.51 $26,304 52,534 D: show line 1 in the form
Open-market sales · 3,091 sh · avg $8.51 · $26,304
Loading xslF345X03/a4.xml…